PainChek's AU$13m Market Cap Boost Amid 72% Five-Year Share Price Decline

PainChek (ASX:PCK) has seen a 56% increase in the last quarter, but its share price has still fallen 72% over the last five years. The company's revenue has grown 50% annually, but it is not profitable. The market may be concerned about future profits, so investors should carefully consider growth and balance sheet threats before purchasing.